Treatment variable

NoECT group

B-ECT group

Between-group differences

Selective serotonin re-uptake inhibitors

Pre-Treatment

53% (n = 10)

11% (n = 2)

CC = 0.41, p = 0.005

Follow-Up

32% (n = 6)

32% (n = 6)

CC < 0.001, p = 1.00

Serotonin and norepinephrine reuptake inhibitors

Pre-Treatment

42% (n = 8)

58% (n = 11)

CC = 0.16, p = 0.33

Follow-Up

26% (n = 5)

37% (n = 7)

CC = 0.11, p = 0.49

Tricyclic antidepressants

Pre-Treatment

5% (n = 1)

37% (n = 7)

CC = 0.36, p = 0.017

Follow-Up

16% (n = 3)

26% (n = 5)

CC = 0.13, p = 0.43

Noradrenergic and specific serotonergic antidepressants

Pre-Treatment

16% (n = 3)

16% (n = 3)

CC < 0.001, p = 1.00

Follow-Up

11% (n = 2)

21% (n = 4)

CC = 0.14, p = 0.37

Lithium

Pre-Treatment

5% (n = 1)

42% (n = 8)

CC = 0.40, p = 0.008

Follow-Up

26% (n = 5)

16% (n = 3)

CC = 0.13, p = 0.43

Anticonvulsants

Pre-Treatment

5% (n = 1)

42% (n = 8)

CC = 0.40, p = 0.008

Follow-Up

16% (n = 3)

16% (n = 3)

CC < 0.001, p = 1.00

Benzodizepines

Pre-Treatment

26% (n = 5)

68% (n = 13)

CC = 0.39, p = 0.009

Follow-Up

32% (n = 6)

26% (n = 5)

CC = 0.06, p = 0.72

Nonbenzodiazepine hypnotics

Pre-Treatment

53% (n = 10)

53% (n = 10)

CC < 0.001, p = 1.00

Follow-Up

26% (n = 5)

26% (n = 5)

CC < 0.001, p = 1.00

Antipsychotics

Pre-Treatment

21% (n = 4)

63% (n = 12)

CC = 0.39, p = 0.009

Follow-Up

26% (n = 5)

47% (n = 9)

CC = 0.21, p = 0.18

Total number of psychotropic medication

Pre-Treatment

Mean = 2.37; SD = 0.96

Mean = 4.47; SD = 1.39

t(36) = 5.44, p < 0.001

Follow-Up

Mean = 2.21; SD = 0.79

Mean = 2.36; SD = 1.57

t(36) = 0.39, p = 0.70

Number of ECT treatments

-

Mean = 8.58; SD = 2.36

-